PERAN WHEY-ACIDIC-PROTEIN FOUR DISULFIDE CORE DOMAIN 2 (WFDC2) SEBAGAI BIOMARKER MUTAKHIR DALAM DETEKSI DAN DIAGNOSIS DINI KANKER OVARIUM

Main Article Content

Natalia Desy

Abstract

Introduction: Ovarian cancer has a major role as the causes of prevalence and deaths
worldwide and has been estimated at 2025 they will rise over heart disease as the largest
cause of death. Indonesia is one of the developing countries that have the death rate
from ovarian cancer is the third-highest in Asia after China and India. The prevalence of
ovarian cancer could be suppressed if the detection and early diagnosis can be
established. However, detection of which is currently used is CA125 is still inadequate as
a diagnosis of early-stage ovarian cancer because this biomarker has high sensitivity and
specificity only at an advanced stage which is the stage is already quite late to be treated.
Discussion: The overexpression WFDC in vitro and in vivo indicate a significant
contribution to the proliferation, cell growth rate, invasive capability, and independent
growth in tumor cells. Additionally, WFDC2 has a higher sensitivity and specificity in
early-stage cancer (stage 1 and 2) compared to CA125 and combination of
CA125+WFDC2 so it is very advantageous for clinician to detect ovarian cancer earlier.
Conclusion: WFDC2 can be used as a biomarker for the detection and early diagnosis of
ovarian cancer.

Article Details

How to Cite
Desy, N. (2021). PERAN WHEY-ACIDIC-PROTEIN FOUR DISULFIDE CORE DOMAIN 2 (WFDC2) SEBAGAI BIOMARKER MUTAKHIR DALAM DETEKSI DAN DIAGNOSIS DINI KANKER OVARIUM. JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia, 6(1), 9-18. Retrieved from https://bapin-ismki.e-journal.id/jimki/article/view/376
Section
Article Review

References

1. Ovarian Cancer - Cancer Stat
Facts [Internet]. Available from:
https://seer.cancer.gov/statfacts/
html/ovary.html
2. Gong T-T, Wu Q-J, Vogtmann
E, Lin B, Wang Y-L. Age at
menarche and risk of ovarian
cancer: A meta-analysis of
epidemiological studies. Int J
options. Womens Health.
2015;11:261–3.
8. Symptoms Associated With
Ovarian Cancer : Clinical
Obstetrics and Gynecology
[Internet]. LWW. Available from:
http://journals.lww.com/clinicalo
bgyn/Fulltext/2012/03000/Sympt
oms_Associated_With_Ovarian
_Cancer.5.aspx
9. Prat J. Staging classification for
cancer of the ovary, fallopian
tube, and peritoneum. Int J
Gynecol Obstet.
2014
Jan;124:1–5.
10. Longuespée R, Boyon C,
Desmons A, Vinatier D, Leblanc
E, Farré I, et al. Ovarian cancer
molecular pathology. Cancer
Metastasis Rev. 2012 Dec;
31:713–32.
Cancer. 2013 Jun;132:2894–
900.
3. C LV. Ovarian cancer:
epidemiology and risk factors.
Eur J Cancer Prev Off J Eur
Cancer Prev Organ ECP
[Internet]. 2016 2016; Available
from:
http://europepmc.org/abstract/m
ed/26731563
4. Malvezzi M, Carioli G,
Rodriguez T, Negri E, Vecchia
CL. Global
trends and
11. Simmons AR, Baggerly K, Bast
RC. The Emerging Role of HE4
in the Evaluation of Epithelial
Ovarian and Endometrial
Carcinomas. Oncology. 2013
Jun;27:548–56.
12. Galgano MT, Hampton GM,
Frierson HF. Comprehensive
analysis of HE4 expression in
normal and malignant human
tissues. Mod Pathol. 2006
Jun;19:847–53.
13. Jiang S-W, Chen H, Dowdy S,
Fu A, Attewell J, Kalogera E, et
al. HE4 Transcription- and
Splice
predictions in ovarian cancer
mortality. Ann Oncol. 2016
Nov;27:2017–25.
5. The incidence and mortality of
ovarian cancer and
Variants-Specific
Expression
in Endometrial
their
relationship with the Human
Development Index in Asia
[Internet]. Available
from:
https://www.ncbi.nlm.nih.gov/pm
Cancer and Correlation with
Patient Survival. Int J Mol Sci.
2013;14:22655–77.
14. Bouchard D, Morisset D,
Bourbonnais Y, Tremblay GM.
c/articles/PMC4817525/
6. Cancer S of Ovarian. Ovarian
Cancer and Body Size:
Individual Participant MetaAnalysis
Including 25,157
Proteins with whey-acidicprotein

motifs and cancer.
Lancet Oncol. 2006 Feb;7:167–
74.
15. Chen Y, Mu X, Wang S, Zhao L,
Wu Y, Li J, et al. WAP fourdisulfide

core domain protein 2
mediates the proliferation of
human ovarian cancer cells
through
Women with Ovarian Cancer
from 47 Epidemiological
Studies. PLoS Med [Internet].
2012 Apr. Available from:
http://search.proquest.com/docv
iew/1288096351/abstract/FAB9
the regulation of
growth-and
apoptosis-
D2AF371B4B13PQ/1
7. Farghaly SA. Ovarian cancer in
obese women: risk and optimal
medical and surgical treatment
associated genes. Oncol Rep.
2013;29:288–96.
16. Li J, Chen H, Mariani A, Chen
D, Klatt E, Podratz K, et al. HE4
(WFDC2) promotes
tumor
growth in endometrial cancer
cell lines. Int J Mol Sci.
2013;14:6026–6043.
17. Bouchard D, Morisset D,
Bourbonnais Y, Tremblay GM.
Proteins with whey-acidicprotein

motifs and cancer.
Lancet Oncol. 2006 Feb;7:167–
74.
18. Ghasemi N, Ghobadzadeh S,
Zahraei M, Mohammadpour H,
Bahrami S, Ganje MB, et al.
HE4 combined with CA125:
favorable screening tool for
ovarian cancer. Med Oncol.
2014 Jan;31:1–6